BioAntibody Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14.4M
- Investors
-
5
BioAntibody General Information
Description
Developer of core raw materials designed for in vitro diagnostics (IVD) and biopharmaceuticals. The company's materials are based on original high-efficiency targeted hybridoma cell fusion technology and supporting stable cell growth factors and high-through-put screening that cover cardiovascular, cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, enabling customers to attain higher quality raw materials for better disease detection and therapy.
Contact Information
Website
www.bioantibody.com.cnCorporate Office
- Room 903/905, Building C6
- 9 Weidi Road
- Nanjing, Jiangsu
- China
Corporate Office
- Room 903/905, Building C6
- 9 Weidi Road
- Nanjing, Jiangsu
- China
BioAntibody Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 11-Jan-2023 | $14.4M | Completed | Generating Revenue |
BioAntibody Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Fangsheng Investment Management Center | Growth/Expansion | Minority | ||
| Bondshine Capital | Venture Capital | Minority | ||
| Guoqian Venture Capital | Venture Capital | Minority | ||
| Nanjing Xingong Emerging Industry Investment Management | Growth/Expansion | Minority | ||
| Phoenix Tree Capital | Investment Bank | Minority |
BioAntibody FAQs
-
When was BioAntibody founded?
BioAntibody was founded in 2019.
-
Where is BioAntibody headquartered?
BioAntibody is headquartered in Nanjing, China.
-
What industry is BioAntibody in?
BioAntibody’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is BioAntibody a private or public company?
BioAntibody is a Private company.
-
What is BioAntibody’s current revenue?
The current revenue for BioAntibody is .
-
How much funding has BioAntibody raised over time?
BioAntibody has raised $14.4M.
-
Who are BioAntibody’s investors?
Beijing Fangsheng Investment Management Center, Bondshine Capital, Guoqian Venture Capital, Nanjing Xingong Emerging Industry Investment Management, and Phoenix Tree Capital have invested in BioAntibody.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process